There were positive relationships between circulating concentrations of sclerostin and markers of bone metabolism, i.e. osteocalcin a marker of bone formation and beta-cross-laps marker of bone resorption in all thyroid patients. This evidence concerns the gene BGLAP and thyroid gland disorder.